학술논문

Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy.
Document Type
Article
Source
Breast Care; Dec2018, Vol. 13 Issue 6, p425-433, 9p, 1 Diagram, 2 Charts, 2 Graphs
Subject
ANTHRACYCLINES
BREAST cancer prognosis
BREAST tumor diagnosis
BREAST tumor treatment
BREAST tumor risk factors
CANCER patients
COMBINED modality therapy
FORMALDEHYDE
HISTOLOGICAL techniques
HORMONES
LONGITUDINAL method
LYMPH nodes
MEDICAL needs assessment
MEDICAL cooperation
POLYMERASE chain reaction
RESEARCH
SURVIVAL
THERAPEUTICS
TRANSCRIPTION factors
TUMOR markers
TREATMENT effectiveness
DNA methylation
ODDS ratio
Language
ISSN
16613791
Abstract
Copyright of Breast Care is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)